BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8028193)

  • 41. Tissue factor: beyond coagulation in the cardiovascular system.
    Breitenstein A; Camici GG; Tanner FC
    Clin Sci (Lond); 2009 Oct; 118(3):159-72. PubMed ID: 19845509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling?
    Versteeg HH; Peppelenbosch MP; Spek CA
    Thromb Haemost; 2001 Dec; 86(6):1353-9. PubMed ID: 11776298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases.
    Sase T; Wada H; Kamikura Y; Kaneko T; Abe Y; Nishioka J; Nobori T; Shiku H
    Thromb Haemost; 2004 Jul; 92(1):132-9. PubMed ID: 15213854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene targeting in hemostasis. tissue factor.
    Mackman N
    Front Biosci; 2001 Feb; 6():D208-15. PubMed ID: 11171553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Interaction of tissue and blood factors in consumption coagulopathies and fibrinolysis].
    Nijs M; Brassinne C; Coune A; Tagnon HJ
    Bull Acad R Med Belg; 1967; 7(7):643-60. PubMed ID: 5621729
    [No Abstract]   [Full Text] [Related]  

  • 46. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.
    Drake TA; Morrissey JH; Edgington TS
    Am J Pathol; 1989 May; 134(5):1087-97. PubMed ID: 2719077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitigation of monocyte driven thrombosis on cobalt chrome surfaces in contact with whole blood by thin film polar/hydrophobic/ionic polyurethane coatings.
    Gossart A; Letourneur D; Gand A; Regnault V; Ben Mlouka MA; Cosette P; Pauthe E; Ollivier V; Santerre JP
    Biomaterials; 2019 Oct; 217():119306. PubMed ID: 31271854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Coagulation in the context of cancer].
    Sánchez-Fayos J
    Rev Clin Esp; 1983 May; 169(3):153-6. PubMed ID: 6193569
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of tissue factor in the pathogenesis of thrombosis and atherosclerosis.
    Asada Y; Marutsuka K; Hatakeyama K; Sato Y; Hara S; Kisanuki A; Sumiyoshi A
    J Atheroscler Thromb; 1998; 4(3):135-9. PubMed ID: 9730145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Tissue factors in the pathogenesis of thrombus formation in oncological gynecology patients].
    Mikhaĭlov VD
    Vopr Onkol; 1979; 25(3):14-7. PubMed ID: 433197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of thrombogenic factors in the development of atherosclerosis.
    Marutsuka K; Hatakeyama K; Yamashita A; Asada Y
    J Atheroscler Thromb; 2005; 12(1):1-8. PubMed ID: 15725689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Possibility of Coagulation System Activation Determination with Tissue Factor in Pregnancy Complications.
    Slavik L; Novak M; Ulehlova J; Prochazka M; Prochazkova J; Lattova V; Polak P; Pilka R
    Clin Lab; 2016 Oct; 62(10):1851-1856. PubMed ID: 28164533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New functions of neutrophils in the arthus reaction: expression of tissue factor, the clotting initiator, and fibrinolysis by elastase.
    Imamura T; Kaneda H; Nakamura S
    Lab Invest; 2002 Oct; 82(10):1287-95. PubMed ID: 12379763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue factor, thrombin, and cancer.
    Rickles FR; Patierno S; Fernandez PM
    Chest; 2003 Sep; 124(3 Suppl):58S-68S. PubMed ID: 12970125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Plasma thromboplastinogenesis in peripheral vascular diseases].
    Coccheri S; Fiorentini P; Pagliani G; Gennari P
    G Clin Med; 1965 Nov; 46(11):1029-39. PubMed ID: 5862248
    [No Abstract]   [Full Text] [Related]  

  • 56. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.
    Bugge TH; Xiao Q; Kombrinck KW; Flick MJ; Holmbäck K; Danton MJ; Colbert MC; Witte DP; Fujikawa K; Davie EW; Degen JL
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6258-63. PubMed ID: 8692802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A coagulation defect arising from heterozygous premature termination of tissue factor.
    Schulman S; El-Darzi E; Florido MH; Friesen M; Merrill-Skoloff G; Brake MA; Schuster CR; Lin L; Westrick RJ; Cowan CA; Flaumenhaft R; ; Ouwehand WH; Peerlinck K; Freson K; Turro E; Furie B
    J Clin Invest; 2020 Oct; 130(10):5302-5312. PubMed ID: 32663190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue factor.
    Carmeliet P; Collen D
    Int J Biochem Cell Biol; 1998 Jun; 30(6):661-7. PubMed ID: 9695023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue factor in health and disease.
    Williams JC; Mackman N
    Front Biosci (Elite Ed); 2012 Jan; 4(1):358-72. PubMed ID: 22201878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Mechanism of organ damage in hyperthromboplastinemia unrelated to hypoxia].
    Kurgan MI
    Biull Eksp Biol Med; 1987 Feb; 103(2):157-9. PubMed ID: 3814793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.